Application 076606

Type: ANDA
Sponsor: SUN PHARM INDS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	100MG	No	No
002	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	300MG	No	No
003	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	400MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076606-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07
A076606-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07
A076606-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`79d66fd596c7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 20 · 394 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	ba4d863d-be38-8cf5-e053-2995a90a69fb	2026-06-26	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	c85ae572-9893-629e-e053-2995a90a23fc	2026-06-26	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Zhejiang Yongtai Pharmaceutical Co., Ltd	f1eda6cc-d9b2-4df4-a09b-20eebded760f	2026-06-25	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Northwind Health Company, LLC	552912b2-be59-0333-e063-6394a90a85c0	2026-06-25	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Northwind Health Company, LLC	55292235-bf8f-46d0-e063-6294a90a91a5	2026-06-25	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Unit Dose Solutions, Inc.	54ecc64b-f019-9fcb-e063-6294a90a00af	2026-06-23	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Unit Dose Solutions, Inc.	54edd6f3-06c7-a0c7-e063-6394a90a8b4f	2026-06-23	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Teva Pharmaceuticals, Inc.	c7f21eaa-68ee-420c-9c98-e997cc73a297	2026-06-23	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Northwind Health Company, LLC	1b44a3ab-4d06-205f-e063-6294a90af368	2026-06-22	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Unit Dose Solutions, Inc.	54dc347e-cba0-ea73-e063-6294a90ab436	2026-06-22	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	St. Mary's Medical Park Pharmacy	235a6954-318a-9e3a-e063-6394a90a0e21	2026-06-19	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	Bryant Ranch Prepack	c9f0cceb-b24e-4526-b873-fedd877d6bc6	2026-06-18	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	Granules Pharmaceuticals Inc	c681c804-c6f3-d63b-e053-2995a90a6b8f	2026-06-17	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Asclemed USA, Inc.	9a829dc3-b2d8-4d19-a579-0597217cec9b	2026-06-17	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	d8604417-9d43-4d27-a7ce-d4120ff201f4	2026-06-11	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	b7a29b99-ce23-950e-e053-2995a90a1934	2026-06-09	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	4c49d34d-bb47-406b-8f2d-b4834b2ee9d0	2026-06-08	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Coupler LLC	5385e27c-f2fa-32d5-e063-6294a90a0a8c	2026-06-05	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Ascend Laboratories, LLC	4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a	2026-06-04	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	St. Mary's Medical Park Pharmacy	07f07d15-ee91-8c2a-e063-6394a90a4624	2026-06-03	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 3 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
63304-627	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current
63304-628	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current
63304-629	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current